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SUMMARY
Vibrio vulnificus (Vv) can result in severe disease. Although pre-existing liver disease is a 
recognized risk factor for serious infection, the relative importance of other comorbidities has not 
been fully assessed. We analysed reports of Vv infections submitted to CDC from January 1988 to 
September 2006 in order to assess the role of pre-existing conditions contributing to severe 
outcomes. A total of 1212 patients with Vv infection were reported. Only patients with liver 
disease [adjusted odds ratio (aOR) 5·1)] were more likely to become septic when exposure was 
due to contaminated food. Patients with liver disease (aOR 4·1), a haematological disease (aOR 
3·2), or malignancy (aOR 3·2) were more likely to become septic when infection was acquired via 
a non-foodborne exposure. As such, patients with these pre-existing medical conditions should be 
advised of the risk of life-threatening illness after eating undercooked contaminated seafood or 
exposing broken skin to warm seawater.
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Vibrio vulnificus (Vv), a Gram-negative rod, was first isolated by the Centers for Disease 
Control and Prevention (CDC) in 1964 and identified as a human pathogen in 1976 [1]. 
Blake et al. initially described the epidemiology, including mode of transmission, routes of 
transmission and risk factors of Vv, which cause an estimated 200 infections annually in the 
USA, nearly half of which are foodborne in origin [2, 3]. In the USA, Vv, which naturally 
occur in marine and estuarine environments and are related to a host of environmental 
parameters including sea surface temperatures, are found in high numbers in the Gulf of 
Mexico [4, 5]. Massive flooding from the Gulf of Mexico in 2005, consequent to Hurricane 
Katrina resulted in 14 reported cases of Vv wound infection, probably via broken skin 
contact with seawater, and three Vv-attributed deaths [6]. Infection may also result from 
eating contaminated seafood, typically raw oysters harvested from the Gulf. Although the 
numbers of annual cases are relatively low, the severity of infection is high, with over 90% 
of infected patients requiring hospitalization and an estimated case-fatality rate of 34·9% [3]. 
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Severe disease with a fatal outcome is more prevalent in those with pre-disposing medical 
conditions and Vv is a leading cause of seafood-associated fatalities in the USA [7, 8]. 
Despite continued prevention efforts, data from both active and passive surveillance systems 
report increasing rates of infection [9].
Although pre-existing liver disease is a recognized risk factor for serious infection, the 
relative importance of other comorbidities, by route of exposure, has not been fully assessed.
The Cholera and Other Vibrio Illness Surveillance System (COVIS) was initiated by CDC, 
FDA, and the Gulf Coast states (Alabama, Florida, Louisiana, Mississippi, Texas) in 1988. 
CDC has maintained a database of Vibrio infections from humans in order to obtain data on 
illnesses associated with Vibrio spp. Participating health officials collect clinical data, 
information about underlying illness, history of seafood consumption, and exposure to 
seawater during the 7 days before illness. When possible, this information assists in 
epidemiological investigations to identify the implicated vehicle. Prior to 2007, toxigenic 
Vibrio cholerae O1 and O139, the causative agents of cholera, were the only nationally 
notifiable species. Despite sporadic reports from other states (non-coastal and Pacific and 
Atlantic coasts), the expansion of COVIS in 1997 marked the point when nearly all states 
were voluntarily reporting all Vibrio spp. Indeed, by 1997, all but one state had reported 
Vibrio cases to COVIS. Infection with any Vibrio spp. (vibriosis) became nationally 
reportable in 2007.
State and county health departments report infection of all species, along with demographic 
(e.g. age, sex), clinical (including pre-existing medical conditions), and exposure data (i.e. 
seafood consumption, travel history, skin exposure to seawater, drippings from raw or live 
seafood, or contact with marine wildlife) to the CDC via a standardized reporting form. Pre-
existing medical conditions, including diabetes, heart disease, haematological disease (e.g. 
anaemia, thalassaemia), immunodeficiency, malignancy, peptic ulcer disease, gastric 
surgery, renal disease and liver disease are specified on the reporting form. In this analysis, 
reported alcoholism was coded as a proxy for liver disease. Data on the source of the 
specimen and the species isolated are also reported; molecular data are not collected.
We analysed reports of Vv infections submitted to COVIS from January 1988 to September 
2006. The source of Vv exposure was determined by clinical signs and patient’s history, and 
was characterized as either foodborne or non-foodborne. A non-foodborne infection required 
isolation of Vv from a wound or from another source (e.g. external ear, skin) with 
documented direct contact with saltwater, marine wildlife, raw seafood, or seafood 
drippings. All other infections were considered foodborne. Septicaemia was defined as 
isolation of the pathogen from the blood in patients with self-reported fever and hypotension 
(systolic blood pressure <90 mmHg). We categorized medical conditions as ‘present’ if the 
report indicated the patient had the diagnosis. Otherwise, the condition was considered ‘not 
present’. Cases with multiple Vibrio spp. were excluded from analysis.
Here we assess pre-existing medical conditions as risk factors for septic vs. non-septic Vv 
infection, by route of exposure (foodborne and non-foodborne). We conducted both 
bivariate analysis [odds ratio (OR), χ2 test for significance] and logistic regression. The 
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initial multivariate model included all significant variables from the bivariate analysis. The 
final model excluded non-significant factors from the initial multivariate model. A 
population attributable risk percentage was calculated:
A total of 1212 patients with Vv infection were reported; 86% were male, 87% were 
hospitalized, 72% were septic, and 33% died. The median age of patients with an infection 
was 56 years. Nearly half (48%) were classified as a non-foodborne infection; the remaining 
cases were classified as foodborne. At least one pre-existing medical condition was reported 
for 80% of patients; liver disease was most prevalent (40%), followed by heart disease 
(23%), diabetes (20%), and renal disease (10%). The prevalence of the other pre-existing 
conditions was each <10%. Patients who acquired infection via contaminated food were 
significantly more likely to be female (15% vs. 11%), younger (55 vs. 58 years), non-white 
(30% vs. 15%), have a greater number of pre-existing medical conditions (1·5 vs. 1·1) and 
become septic (87% vs. 55%) than those patients who acquired a non-foodborne infection.
Nearly 2/3 (63%) of the septic cases were acquired via contaminated food while the majority 
(77%) of non-septic cases were non-foodborne infections. Of the patients who were septic, 
87% were male. The case-fatality rate of septic cases was 44%; of non-septic cases only 7% 
died.
Pre-existing medical conditions differed in septic vs. non-septic cases and by route of 
exposure (Table 1). On bivariate analysis of pre-existing medical conditions associated with 
Vv septicaemia from a food-borne exposure, patients with liver disease, haematological 
disease, diabetes, or peptic ulcer disease were more likely to develop septicaemia. On 
bivariate analysis of pre-existing medical conditions associated with Vv septicaemia from a 
non-foodborne exposure, patients with liver disease, malignancy, haematological disease, 
heart disease, or diabetes were more likely to be septic.
Using logistic regression and adjusting for age, sex, and the number of pre-existing 
conditions, only patients with liver disease (aOR 5·1) were more likely to become septic 
when exposure was due to contaminated food. Patients with liver disease (aOR 4·1), a 
haematological disease (aOR 3·2), or malignancy (aOR 3·2) were more likely to become 
septic when infection was acquired via a non-foodborne exposure (Table 2). Having 
multiple pre-existing conditions was associated with severe illness. However, in patients 
with vibriosis who developed septicaemia, only liver disease had an attributable risk 
percentage >10% (24% of non-foodborne infections; 47% of foodborne infections).
Vv infection results in high morbidity and mortality. Over 70% of infected patients become 
septic, of which significantly more patients become septic after acquiring infection via a 
foodborne exposure, and nearly half of septic patients die. Liver disease has already been 
well characterized as a host risk factor for serious infection, including sepsis and death [4, 5, 
8, 10, 11]. In this analysis, we included other potential risk factors and found that only 
persons with liver disease, were at increased risk of developing septicaemia for both 
foodborne and non-foodborne exposure. Patients with a haematological disease, or an 
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underlying malignancy, were at increased risk of developing septicaemia with a non-
foodborne infection, but were not at increased risk if the exposure was foodborne. Although 
the reason for this discrepancy is unknown, both of these conditions may alter the immune 
system and impair wound healing, and are documented risk factors for other invasive 
bacterial infections [12].
Given that the results presented here are from a case-series analysis, we cannot determine 
the individual risk of infection for patients with specific conditions. Due to the relatively low 
percentage of patients with certain pre-existing conditions [e.g. malignancy (9%) or 
haematological disease (8%)], this analysis is unable to provide information on the 
importance of a specific type of condition (e.g. breast cancer). Moreover, this analysis is 
unable to characterize the severity of conditions (e.g. stage of malignancy, degree of 
neutropenia) associated with sepsis because such information is not currently collected in 
this surveillance system. Additionally, as we did not have molecular typing data, we were 
unable to evaluate the role of risk factors by particular Vv strain. This analysis covers data 
reported to COVIS from 1988 to 2006, which corresponds to the time period from the 
initiation of this surveillance system until the time that vibriosis became a nationally 
notifiable disease. While we do not believe the findings presented here will be altered with 
more recent data, continued analysis of surveillance data is necessary. To provide evidence 
for more refined recommendations, future iterations of this surveillance system should 
consider collecting molecular data as well as markers of disease severity.
While the general association between pre-existing medical conditions and Vv infection is 
well known, these results characterize the significance and relative importance of certain 
pre-existing medical conditions, by route of exposure, associated with Vv infection. As such, 
these results underscore the need for clinicians to advise patients with liver disease, 
malignancy, or a haematological condition to avoid exposing broken skin to warm seawater. 
Clinicians should further advise patients, especially patients with liver disease, of the risk of 
life-threatening illness after eating undercooked contaminated seafood. Clinicians should 
consider the diagnosis of Vv for seriously ill patients presenting with a recent history of raw 
shellfish consumption or wound exposure to the Gulf of Mexico or other warm marine 
environments which are likely to harbour Vv, culture specimens, and provide prompt 
treatment, including antibiotics.
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